FDA Adverse Event Malfunction Summary report: N

NC TREK CORONARY DILATATION CATHETER

MDR report key: 3200163 · Received July 1, 2013

Report

Report Number
2024168-2013-04133
Event Type
Malfunction
Date Received
July 1, 2013
Date of Event
June 6, 2013
Report Date
June 6, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
LOX
PMA / PMN Number
K110134
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HK
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR EVALUATION AND THE REPORTED INFLATION ISSUE WAS CONFIRMED. BASED ON THE VISUAL AND FUNCTIONAL ANALYSIS OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. REVIEW OF THE COMPLAINT HISTORY OF THE REPORTED LOT DID NOT INDICATE A MANUFACTURING ISSUE. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT PRODUCT: INFLATION: INDEFLATOR. THE DEVICE WAS RECEIVED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT USING A RADIAL ARTERY ACCESS APPROACH DURING A PROCEDURE OF THE MILDLY CALCIFIED, MILDLY TORTUOUS, DE NOVO MID LEFT ANTERIOR DESCENDING (LAD) ARTERY, THE 2.50 X 8 MM NC TREK BALLOON DILATATION CATHETER (BDC) COULD NOT BE INFLATED. IT WAS NOTED THAT AN INDEFLATOR WAS BEING USED AND THE CONNECTIONS WERE VERIFIED TO BE TIGHT WITHOUT ISSUE. THE CONTRAST DILUTION RATIO USED WAS 1:5. A DIFFERENT DEVICE WAS USED. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
298747 NC TREK CORONARY DILATATION CATHETER CORONARY DILATATION CATHETER LOX AV-TEMECULA-CT 30213G1

Patients

Seq Age Sex Outcome Treatment
1